PubMed:12183467 / 979-1350 JSONTXT

{"project":"GlyCosmos6-Glycan-Motif-Image","denotations":[{"id":"T17","span":{"begin":21,"end":25},"obj":"Glycan_Motif"},{"id":"T19","span":{"begin":29,"end":32},"obj":"Glycan_Motif"},{"id":"T21","span":{"begin":172,"end":175},"obj":"Glycan_Motif"},{"id":"T23","span":{"begin":191,"end":195},"obj":"Glycan_Motif"}],"attributes":[{"id":"A17","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G40183QN"},{"id":"A18","pred":"image","subj":"T17","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G05952XV"},{"id":"A19","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A20","pred":"image","subj":"T19","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A21","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G98544DH"},{"id":"A22","pred":"image","subj":"T21","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81928IQ"},{"id":"A23","pred":"image","subj":"T23","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G40183QN"},{"id":"A24","pred":"image","subj":"T23","obj":"https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G05952XV"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"GlyCosmos6-Glycan-Motif-Structure","denotations":[{"id":"T17","span":{"begin":21,"end":25},"obj":"https://glytoucan.org/Structures/Glycans/G05952XV"},{"id":"T18","span":{"begin":21,"end":25},"obj":"https://glytoucan.org/Structures/Glycans/G40183QN"},{"id":"T19","span":{"begin":29,"end":32},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T20","span":{"begin":29,"end":32},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T21","span":{"begin":172,"end":175},"obj":"https://glytoucan.org/Structures/Glycans/G81928IQ"},{"id":"T22","span":{"begin":172,"end":175},"obj":"https://glytoucan.org/Structures/Glycans/G98544DH"},{"id":"T23","span":{"begin":191,"end":195},"obj":"https://glytoucan.org/Structures/Glycans/G05952XV"},{"id":"T24","span":{"begin":191,"end":195},"obj":"https://glytoucan.org/Structures/Glycans/G40183QN"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"sentences","denotations":[{"id":"T7","span":{"begin":0,"end":371},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":21,"end":25},"obj":"http://www.glycoepitope.jp/epitopes/EP0067"},{"id":"T6","span":{"begin":191,"end":195},"obj":"http://www.glycoepitope.jp/epitopes/EP0067"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"Glycan-GlyCosmos","denotations":[{"id":"T9","span":{"begin":21,"end":25},"obj":"Glycan"},{"id":"T10","span":{"begin":29,"end":32},"obj":"Glycan"},{"id":"T11","span":{"begin":172,"end":175},"obj":"Glycan"},{"id":"T12","span":{"begin":191,"end":195},"obj":"Glycan"}],"attributes":[{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G40183QN"},{"id":"A23","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G40183QN"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A24","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A25","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G40183QN"},{"id":"A26","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G40183QN"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"GlyCosmos-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":21,"end":25},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T6","span":{"begin":191,"end":195},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0067"},{"id":"A6","pred":"glycoepitope_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0067"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"sentences","denotations":[{"id":"T7","span":{"begin":0,"end":371},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T7","span":{"begin":0,"end":371},"obj":"Sentence"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"GlyCosmos15-Glycan","denotations":[{"id":"T9","span":{"begin":21,"end":25},"obj":"Glycan"},{"id":"T10","span":{"begin":29,"end":32},"obj":"Glycan"},{"id":"T11","span":{"begin":172,"end":175},"obj":"Glycan"},{"id":"T12","span":{"begin":191,"end":195},"obj":"Glycan"}],"attributes":[{"id":"A9","pred":"glycosmos_id","subj":"T9","obj":"https://glycosmos.org/glycans/show/G40183QN"},{"id":"A23","pred":"image","subj":"T9","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G40183QN"},{"id":"A10","pred":"glycosmos_id","subj":"T10","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A24","pred":"image","subj":"T10","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A11","pred":"glycosmos_id","subj":"T11","obj":"https://glycosmos.org/glycans/show/G98544DH"},{"id":"A25","pred":"image","subj":"T11","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G98544DH"},{"id":"A12","pred":"glycosmos_id","subj":"T12","obj":"https://glycosmos.org/glycans/show/G40183QN"},{"id":"A26","pred":"image","subj":"T12","obj":"https://api.glycosmos.org/wurcs2image/latest/png/binary/G40183QN"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}

{"project":"GlyCosmos15-GlycoEpitope","denotations":[{"id":"T5","span":{"begin":21,"end":25},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"},{"id":"T6","span":{"begin":191,"end":195},"obj":"http://purl.jp/bio/12/glyco/glycan#Glycan_epitope"}],"attributes":[{"id":"A5","pred":"glycoepitope_id","subj":"T5","obj":"http://www.glycoepitope.jp/epitopes/EP0067"},{"id":"A6","pred":"glycoepitope_id","subj":"T6","obj":"http://www.glycoepitope.jp/epitopes/EP0067"}],"text":"Modulation of either GT1b or GD3 content affected phosphoinositol 3-kinase activation, and inhibition of this activation reversed the stimulation of cell spreading by anti-GD3 antibody, anti-GT1b antibody, and ganglioside depletion, suggesting that phosphoinositol 3-kinase is an intermediate in both the FAK/Src and protein kinase C pathways that lead to cell spreading."}